Striatal and Extrastriatal Dopamine Transporter Availability in Schizophrenia and Its Clinical Correlates: A Voxel-Based and High-Resolution PET Study
暂无分享,去创建一个
J. Martinot | E. Artiges | M. d’Albis | E. Tzavara | C. Trichard | A. Pépin | C. Leroy | M. Dubol | Marie Prat | Audrey Mabondo | R. de Beaurepaire | B. Beaufils | Jean-Pierre Korwin | A. Galinowski | M. Santiago-Ribeiro | B. Granger
[1] J. Martinot,et al. Dopamine Transporter Correlates and Occupancy by Modafinil in Cocaine-Dependent Patients: A Controlled Study With High-Resolution PET and [11C]-PE2I , 2016, Neuropsychopharmacology.
[2] A. Falini,et al. Abnormal cortico-limbic connectivity during emotional processing correlates with symptom severity in schizophrenia , 2015, European Psychiatry.
[3] Hui-Feng Duan,et al. A longitudinal study on intrinsic connectivity of hippocampus associated with positive symptom in first-episode schizophrenia , 2015, Behavioural Brain Research.
[4] Hanzhang Lu,et al. Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia. , 2015, The American journal of psychiatry.
[5] Adrian Preda,et al. Visual hallucinations are associated with hyperconnectivity between the amygdala and visual cortex in people with a diagnosis of schizophrenia. , 2015, Schizophrenia bulletin.
[6] Michael W. Cole,et al. Amygdala connectivity differs among chronic, early course, and individuals at risk for developing schizophrenia. , 2014, Schizophrenia bulletin.
[7] T. Boraud,et al. The Michelin red guide of the brain: role of dopamine in goal-oriented navigation , 2014, Front. Syst. Neurosci..
[8] Federico Turkheimer,et al. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. , 2013, Brain : a journal of neurology.
[9] B. Bogerts,et al. Hippocampal CA1 deformity is related to symptom severity and antipsychotic dosage in schizophrenia. , 2013, Brain : a journal of neurology.
[10] A. Meyer-Lindenberg,et al. Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density. , 2013, Schizophrenia bulletin.
[11] A. Meyer-Lindenberg,et al. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies. , 2013, Schizophrenia bulletin.
[12] Claude Comtat,et al. Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high‐resolution PET study , 2012, Addiction biology.
[13] Mark Slifstein,et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. , 2012, Archives of general psychiatry.
[14] T Warbrick,et al. Hippocampal subfields predict positive symptoms in schizophrenia: First evidence from brain morphometry , 2012, Translational Psychiatry.
[15] Christer Halldin,et al. Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter — Application to juvenile myoclonic epilepsy , 2012, NeuroImage.
[16] J. Lieberman,et al. Presynaptic regulation of dopamine transmission in schizophrenia. , 2011, Schizophrenia bulletin.
[17] J. Goldstein,et al. Sex differences in schizophrenia , 2010, International review of psychiatry.
[18] I. Kanno,et al. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models , 2010, Annals of nuclear medicine.
[19] Angus W. MacDonald,et al. The functional neuroanatomy of symptom dimensions in schizophrenia: A qualitative and quantitative review of a persistent question , 2010, Neuroscience & Biobehavioral Reviews.
[20] Harumasa Takano,et al. Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter. , 2009, Journal of psychiatric research.
[21] Christine DeLorenzo,et al. Modeling Considerations for In Vivo Quantification of the Dopamine Transporter using [11C]PE2I and Positron Emission Tomography , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] Andrew J. Reader,et al. Impact of Image-Space Resolution Modeling for Studies with the High-Resolution Research Tomograph , 2008, Journal of Nuclear Medicine.
[23] H. Möller,et al. Dual-isotope SPECT imaging of striatal dopamine: First episode, drug naïve schizophrenic patients , 2008, Schizophrenia Research.
[24] Harumasa Takano,et al. Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography , 2008, NeuroImage.
[25] Christer Halldin,et al. Measurement of Striatal and Extrastriatal Dopamine Transporter Binding with High-Resolution PET and [11C]PE2I: Quantitative Modeling and Test—Retest Reproducibility , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[26] Po See Chen,et al. Decreased dopamine transporter availability in male smokers — A dual isotope SPECT study , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[27] Caryn Lerman,et al. Dopamine Transporter Binding in Smokers and Nonsmokers , 2007, Clinical nuclear medicine.
[28] Claude Comtat,et al. Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT , 2007, Journal of Nuclear Medicine.
[29] Ronald Boellaard,et al. Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner , 2007, Physics in medicine and biology.
[30] J. Seidel,et al. Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[31] E. Fernandez-Egea,et al. Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait , 2007, Psychopharmacology.
[32] Christer Halldin,et al. Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[33] J. Leon,et al. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors , 2005, Schizophrenia Research.
[34] M. Bannon. The dopamine transporter: role in neurotoxicity and human disease. , 2005, Toxicology and applied pharmacology.
[35] L. Siever,et al. Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide , 2004, Biological Psychiatry.
[36] J. Sundsfjord,et al. 123I-β-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia , 2004, Psychopharmacology.
[37] Yuan-Hwa Chou,et al. [11C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[38] S. Kapur. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. , 2003, The American journal of psychiatry.
[39] J. Hietala,et al. Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects , 2002, Biological Psychiatry.
[40] R. Gur,et al. Striatal dopamine transporters and cognitive functioning in healthy men and women. , 2001, The American journal of psychiatry.
[41] D. Linszen,et al. Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT , 2001, Schizophrenia Research.
[42] C. Crouzel,et al. Highly efficient synthesis of [11C]PE2I, a selective radioligand for the quantification of the dopamine transporter using PET , 2000 .
[43] F. Tarazi,et al. Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain , 2000, Neuroscience Letters.
[44] L. Reneman,et al. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers , 2000, European Journal of Nuclear Medicine.
[45] J. Krystal,et al. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [123I]β-CIT , 2000, Biological Psychiatry.
[46] L. Reneman,et al. [123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication , 2000, European Journal of Nuclear Medicine.
[47] Ralph Myers,et al. Assessment of Spatial Normalization of PET Ligand Images Using Ligand-Specific Templates , 1999, NeuroImage.
[48] R. Blakely,et al. Pharmacological profile of neuroleptics at human monoamine transporters. , 1999, European journal of pharmacology.
[49] D. Guilloteau,et al. Visualization of the Dopamine Transporter in the Human Brain Postmortem with the New Selective Ligand [125I]PE2I , 1999, NeuroImage.
[50] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.
[51] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[52] F. Carroll,et al. Characterization and localization of [125I]RTI-121 binding sites in human striatum and medial temporal lobe. , 1995, The Journal of pharmacology and experimental therapeutics.
[53] Karl J. Friston,et al. Statistical parametric maps in functional imaging: A general linear approach , 1994 .
[54] Jeffrey A. Lieberman,et al. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia , 1993, Biological Psychiatry.
[55] K. Davis,et al. Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.
[56] L. Kozlowski,et al. Nicotine addiction and its assessment. , 1990, Ear, nose, & throat journal.
[57] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[58] B. Berger,et al. Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat , 1985, Neuroscience.
[59] B. Bogerts,et al. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. , 1983, Biological psychiatry.
[60] Herve Simon,et al. Origin of dopaminergic innervation of the rat hippocampal formation , 1980, Neuroscience Letters.